Intermittent short course enzalutamide in biochemically recurrent prostate cancer: Analysis of PSA recovery, testosterone levels and tolerabilityMunjid Al Harthy, Ravi A. Madan, Fatima Karzai et al.|Annals of Oncology|2018Cited by 1